Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

2018 ◽  
Vol 12 (2) ◽  
pp. 133-142 ◽  
Author(s):  
Tomomi Okubo ◽  
Masanori Atsukawa ◽  
Akihito Tsubota ◽  
Hidenori Toyoda ◽  
Noritomo Shimada ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Renal Impairment ◽  
Chronic Hepatitis C ◽  
Moderate Renal Impairment ◽  
Efficacy And Safety ◽  
Genotype 1B ◽  
Chronic Hepatitis C Patients

scholarly journals Efficacy and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Genotype 1b Chronic Hepatitis C Patients with and without Cirrhosis Undergoing Hemodialysis

Kanzo ◽  
2018 ◽  
Vol 59 (10) ◽  
pp. 578-580
Author(s):  
Masanori Atsukawa ◽  
Chisa Kondo ◽  
Makoto Nakamuta ◽  
Hidenori Toyoda ◽  
Takashi Kumada ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Efficacy And Safety ◽  
Genotype 1B ◽  
Chronic Hepatitis C Patients

scholarly journals Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Hepatology ◽  
2014 ◽  
Vol 59 (6) ◽  
pp. 2426-2426 ◽  
Author(s):  
Véronique Loustaud-Ratti ◽  
Paul Carrier ◽  
Chanlina Vong ◽  
Marie Essig
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Renal Impairment ◽  
Triple Therapy ◽  
Chronic Hepatitis C ◽  
Chronic Hepatitis C Patients

Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong

2017 ◽  
Vol 32 (6) ◽  
pp. 1230-1233 ◽  
Author(s):  
Henry Lik‐Yuen Chan ◽  
Owen Tak‐Yin Tsang ◽  
Yee‐Tak Hui ◽  
James Fung ◽  
Grace Chung‐Yan Lui ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hong Kong ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real Life ◽  
Efficacy And Safety ◽  
Chronic Hepatitis C Patients
Sign in / Sign up

Export Citation Format

Share Document